Lots of irons in the fire could be distracting investors from the most serious problem this company faces right now.
News & Analysis: Tonix Pharmaceuticals Holding
There are some well-known and not-so-well-known names on the list.
They're risky but worth putting on your radar.
This biotech's ambitious development pipeline keeps attracting attention.
It's risky, but it's also intriguing.
The company struck a deal to bolster its COVID-19 pipeline.
These popular Robinhood stocks have two things in common: low share prices and high risk.
There are two main reasons this small-cap biotech stock has gained a lot of attention.
The company reported positive results from a pre-clinical study.
The biotech wants to help doctors measure T-cell immunity to the novel coronavirus.